Clinical Trial Update: Risk Stratification-directed NAC for Prevention of Poor Hematopoietic Reconstitution [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on risk-stratification-directed neoadjuvant or preparative therapy for preventing poor hematopoietic reconstitution after stem cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stem Cell Transplantation Complications

Snippet

Sponsor: Peking University People's Hospital | Conditions: Stem Cell Transplant Complications | Phase 3 | Status: UNKNOWN